Azathioprine suppresses ezrin-radixin-moesin-dependent T Cell-APC conjugation through inhibition of Vav guanosine exchange activity on Rac protein

被引:166
作者
Poppe, D
Tiede, I
Fritz, G
Becker, C
Bartsch, B
Wirtz, S
Strand, D
Tanaka, S
Galle, PR
Bustelo, XR
Neurath, MF [1 ]
机构
[1] Johannes Gutenberg Univ Mainz, Dept Med 1, Immunol Lab, D-55101 Mainz, Germany
[2] Johannes Gutenberg Univ Mainz, Dept Toxicol, D-55101 Mainz, Germany
[3] Hokkaido Univ, Grad Sch Med, Lab Mol & Cellular Pathol, Sapporo, Hokkaido, Japan
[4] Univ Salamanca, Spanish Council Sci Res, Ctr Invest Canc, E-37008 Salamanca, Spain
关键词
D O I
10.4049/jimmunol.176.1.640
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We have shown recently that the azathioprine metabolite 6-Thio-GTP causes immunosuppression by blockade of GTPase activation in T lymphocytes. In the present study, we describe a new molecular mechanism by which 6-Thio-GTP blocks GTPase activation. Although 6-Thio-GTP could bind to various small GTPases, it specifically blocked activation of Rac1 and Rac2 but not of closely related Rho family members such as Cdc42 and RhoA in primary T cells upon stimulation with alpha CD28 or fibronectin. Binding of 6-Thio-GTP to Rac1 did not suppress Rac effector coupling directly but blocked Vav1 exchange activity upon 6-Thio-GTP hydrolysis, suggesting that 6-Thio-GTP loading leads to accumulation of 6-Thio-GDP-loaded, inactive Rac proteins over time by inhibiting Vav activity. In the absence of apoptosis, blockade of Vav-mediated Rac1 activation led to a blockade of ezrin-radixin-moesin dephosphorylation in primary T cells and suppression of T cell-APC conjugation. Azathioprine-generated 6-Thio-GTP thus prevents the development of an effective immune response via blockade of Vav activity on Rac proteins. These findings provide novel insights into the immunosuppressive effects of azathioprine and suggest that antagonists of the Vav-Rac signaling pathway may be useful for suppression of T cell-dependent pathogenic immune responses.
引用
收藏
页码:640 / 651
页数:12
相关论文
共 66 条
[1]  
ABDOU NI, 1973, CLIN EXP IMMUNOL, V13, P55
[2]   Structural basis for relief of autoinhibition of the Dbl homology domain of proto-oncogene Vav by tyrosine phosphorylation [J].
Aghazadeh, B ;
Lowry, WE ;
Huang, XY ;
Rosen, MK .
CELL, 2000, 102 (05) :625-633
[3]   Effect of Y-27632 on release of cytokines from peripheral T cells in asthmatic patients and normal subjects [J].
Aihara, M ;
Dobashi, K ;
Iizuka, K ;
Nakazawa, T ;
Mori, M .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2004, 4 (04) :557-561
[4]   ERM-dependent movement of CD43 defines a novel protein complex distal to the immunological synapse [J].
Allenspach, EJ ;
Cullinan, P ;
Tong, JK ;
Tang, QZ ;
Tesciuba, AG ;
Cannon, JL ;
Takahashi, SM ;
Morgan, R ;
Burkhardt, JK ;
Sperling, AI .
IMMUNITY, 2001, 15 (05) :739-750
[5]   Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation:: Evidence in Crohn disease and experimental colitis in vivo [J].
Atreya, R ;
Mudter, J ;
Finotto, S ;
Müllberg, J ;
Jostock, T ;
Wirtz, S ;
Schütz, M ;
Bartsch, B ;
Holtmann, M ;
Becker, C ;
Strand, D ;
Czaja, J ;
Schlaak, JF ;
Lehr, HA ;
Autschbach, F ;
Schürmann, G ;
Nishimoto, N ;
Yoshizaki, K ;
Ito, H ;
Kishimoto, T ;
Galle, PR ;
Rose-John, S ;
Neurath, MF .
NATURE MEDICINE, 2000, 6 (05) :583-588
[6]   TREATMENT OF CHRONIC ULCERATIVE COLITIS WITH 6-MERCAPTOPURINE [J].
BEAN, RHD .
MEDICAL JOURNAL OF AUSTRALIA, 1962, 2 (15) :592-&
[7]   Constitutive p40 promoter activation and IL-23 production in the terminal ileum mediated by dendritic cells [J].
Becker, C ;
Wirtz, S ;
Blessing, M ;
Pirhonen, J ;
Strand, D ;
Bechthold, O ;
Frick, J ;
Galle, PR ;
Autenrieth, I ;
Neurath, MF .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 112 (05) :693-706
[8]   The immunological and genetic basis of inflammatory bowel disease [J].
Bouma, G ;
Strober, W .
NATURE REVIEWS IMMUNOLOGY, 2003, 3 (07) :521-533
[9]  
Bustelo XR, 2002, HISTOL HISTOPATHOL, V17, P871, DOI 10.14670/HH-17.871
[10]   A CONTROLLED DOUBLE-BLIND-STUDY OF AZATHIOPRINE IN THE MANAGEMENT OF CROHNS-DISEASE [J].
CANDY, S ;
WRIGHT, J ;
GERBER, M ;
ADAMS, G ;
GERIG, M ;
GOODMAN, R .
GUT, 1995, 37 (05) :674-678